# Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant

> **NCT00909948** · PHASE1 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 7 (actual)

## Conditions studied

- Non Hodgkin's Lymphoma
- Hodgkin Disease
- Multiple Myeloma

## Interventions

- **OTHER:** Fludarabine and total body irradiation
- **RADIATION:** Total body irradiation

## Key facts

- **NCT ID:** NCT00909948
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909948, "Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00909948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*